RALEIGH, N.C., March 23, 2011 /PRNewswire/ — PRA International,
a leading Clinical Research Organization, announces that two of our
experts will be speakers at the upcoming Partnerships in Clinical
Trials and Late Phase Drug Development conferences. PRA will also
be exhibiting at both conferences.
Mike Hill, Project Manager for PRA’s Late Phase Services group,
will make a presentation at the Late Phase Drug Development
conference in Boston, MA on 23 March at 11:10 AM EDT. Mr. Hill will
discuss the application of statistics to post-marketing studies in
his speech, “Utilizing Statistical Techniques to Drive Late Phase
Operations”. Attendees can learn more about our late phase and
other services at our exhibition booth.
Mr. Hill has over six years of experience working with global
registries and observational studies. He has designed and managed
large-scale disease, drug and diagnostic registries across multiple
therapeutic areas. PRA’s Late Phase Services group supports global
and regional post-approval studies with management locations
centralized in our Horsham, Pennsylvania and Mannheim, Germany
offices.
Kent Thoelke, Senior Vice President of PRA’s Scientific and
Medical Affairs group, will present at Partnerships in Clinical
Trials being held in Phoenix, Arizona on 31 March at 2:15 PM PDT.
He will discuss collaborative models that sponsors, CROs and
investigative sites are pursuing to improve efficiencies and reduce
costs in his session, “Strategic Sponsor-Site Partnership Models:
Improving Site Selection and Recruiting in a Collaborative
Environment”. PRA representatives will also be available at Booth
#1200 to discuss our experience in supporting clinical trials.
With over 19 years of experience in all aspects of global drug
development, Mr. Thoelke has particular expertise in the execution
of global studies. In his role at PRA, he provides scientific and
strategic oversight of product development to support project teams
and clie
‘/>”/>
